We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$42.6B
AUM Growth
+$2.24B
Cap. Flow
-$691M
Cap. Flow %
-1.62%
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$204M
2
JPM icon
JPMorgan Chase
JPM
+$72.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$67.5M
4
EVRG icon
Evergy
EVRG
+$66.6M
5
NVDA icon
NVIDIA
NVDA
+$58.5M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$370M
2
UPS icon
United Parcel Service
UPS
+$364M
3
D icon
Dominion Energy
D
+$172M
4
MRNA icon
Moderna
MRNA
+$125M
5
TDOC icon
Teladoc Health
TDOC
+$114M

Sector Composition

Rank Sector Weight
1 Healthcare 22.25%
2 Technology 19.89%
3 Consumer Discretionary 10.98%
4 Financials 9.64%
5 Industrials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNAM
276
DELISTED
Avidity Biosciences
RNAM
$35.9M 0.08%
1,273,600
+902,681
+243% +$26.1M
BL icon
277
BlackLine
BL
$1.9B
$35.6M 0.08%
397,500
TTEK icon
278
Tetra Tech
TTEK
$8.77B
$35.5M 0.08%
1,860,455
-6,210
-0.3% -$110K
MAS icon
279
Masco
MAS
$14.3B
$35.4M 0.08%
642,568
+616,032
+2,321% +$34.5M
DAL icon
280
Delta Air Lines
DAL
$56.7B
$35.4M 0.08%
1,157,190
-533,707
-32% -$15.4M
MRTX
281
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$35.1M 0.08%
211,685
+33,735
+19% +$4.62M
ALRM icon
282
Alarm.com
ALRM
$2.75B
$34.9M 0.08%
632,183
+40,948
+7% +$2.53M
BIDU icon
283
Baidu
BIDU
$35.7B
$34.7M 0.08%
274,421
+3,552
+1% +$440K
SMAR
284
DELISTED
Smartsheet Inc.
SMAR
$34.6M 0.08%
700,000
-4,766
-0.7% -$230K
CAMT icon
285
Camtek
CAMT
$5.92B
$34.3M 0.08%
2,230,000
GKOS icon
286
Glaukos
GKOS
$9.49B
$33.8M 0.08%
683,470
SWK icon
287
Stanley Black & Decker
SWK
$14.5B
$33.7M 0.08%
208,031
-3,171
-2% -$494K
ZEN
288
DELISTED
ZENDESK INC
ZEN
$33.2M 0.08%
322,861
CHTR icon
289
Charter Communications
CHTR
$17.3B
$33M 0.08%
52,879
-5,726
-10% -$3.38M
LEGN icon
290
Legend Biotech
LEGN
$3.65B
$33M 0.08%
1,068,217
+904,345
+552% +$30.4M
DKS icon
291
Dick's Sporting Goods
DKS
$18.4B
$32.7M 0.08%
565,774
-18,894
-3% -$920K
IRTC icon
292
iRhythm Holdings
IRTC
$4.02B
$32.6M 0.08%
137,122
+3,109
+2% +$550K
CRNC icon
293
Cerence
CRNC
$359M
$32.6M 0.08%
666,758
LIN icon
294
Linde
LIN
$236B
$32.5M 0.08%
136,448
-19,214
-12% -$4.66M
CRWD icon
295
CrowdStrike
CRWD
$183B
$32.4M 0.08%
944,392
+733,040
+347% +$21.4M
C icon
296
Citigroup
C
$213B
$31.9M 0.07%
739,099
-505,789
-41% -$25.2M
NET icon
297
Cloudflare
NET
$96B
$31.8M 0.07%
775,000
-10,825
-1% -$414K
SNPS icon
298
Synopsys
SNPS
$71.6B
$31.7M 0.07%
148,267
-98,136
-40% -$20M
BIIB icon
299
Biogen
BIIB
$30.9B
$31.7M 0.07%
111,594
-91,748
-45% -$25.6M
CLVT icon
300
Clarivate
CLVT
$1.38B
$31.6M 0.07%
1,020,000

Similar funds

Federated Hermes's Q3 2020 Portfolio in Review

As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
  • Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
  • Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
  • Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
  • Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
  • Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.